Key result
Apolipoprotein A-I drives anti-inflammatory effects by modulating immune cells, endothelium, and adipocytes.
Answers are grounded in this paper and cite their sources.
Apolipoprotein A-I(ApoA-I) is a member of blood apolipoproteins, it is the main component of High density lipoprotein(HDL). ApoA-I undergoes a series of complex processes from its generation to its composition as spherical HDL. It not only has a cholesterol reversal transport function, but also has a function in modulating the inflammatory response. ApoA-I exerts its anti-inflammatory effects mainly by regulating the functions of immune cells, such as monocytes/macrophages, dendritic cells, neutrophils, and T lymphocytes. It also modulates the function of vascular endothelial cells and adipocytes. Additionally, ApoA-I directly exerts anti-inflammatory effects against pathogenic microorganisms or their products. Intensive research on ApoA-I will hopefully lead to better diagnosis and treatment of inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2024) conducted a review in Inflammatory diseases. Apolipoprotein A-I was evaluated. Apolipoprotein A-I exerts anti-inflammatory effects by regulating immune cells, vascular endothelial cells, adipocytes, and acting directly against pathogenic microorganisms.
Synapse has enriched 10 related papers. Consider them for comparative context: